Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles, mRNA cargo delivery and transcription, and cytotoxic responses in real time (Nanoscale Horizons, 2026 https://doi.org/10.1039/D5NH00749F).
Nanoparticle drug delivery systems require the analysis of several processes to assess their function; uptake, cargo release, and effects on cellular viability. This multi-step process is typically studied across separate experiments, each optimized to quantify a single process.
By reducing the use of fluorescent dyes to visualize cellular structures and to detect cell death, Nanolive’s platform enables long-term live cell imaging with reduced phototoxicity, allowing researchers to dynamically investigate nanoparticle uptake, cargo delivery, and cellular response within a single workflow.
Join us to discover how live cell imaging provides:
– Dynamic, real-time data, beyond static endpoint assays
– Reduced phototoxicity for long-term live cell imaging
– Kinetics of nanoparticle uptake and mRNA release and transcription
– Insights into how nanoparticle formulation impacts delivery dynamics
– Label-free insights into drug mechanism of action and cell response
– More physiologically relevant data for translational research
This online event is ideal for R&D researchers and biopharma professionals in the drug delivery field looking to:
– Increase reproducibility with scalable, automated analysis
– Accelerate drug screening and candidate selection with high-content data
– Simplify experimental workflows and data interpretation
– Reduce fragmented assays and complex data integration
– Support more informed decision-making with label-free data
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Move beyond endpoints with dynamic EC50
